KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) FCF Margin (2016 - 2025)

Eli Lilly (LLY) has disclosed FCF Margin for 17 consecutive years, with 3.51% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 371.0% year-over-year to 3.51%, compared with a TTM value of 13.77% through Dec 2025, up 542.0%, and an annual FY2025 reading of 13.77%, up 542.0% over the prior year.
  • FCF Margin was 3.51% for Q4 2025 at Eli Lilly, down from 38.34% in the prior quarter.
  • Across five years, FCF Margin topped out at 38.34% in Q3 2025 and bottomed at 14.79% in Q4 2023.
  • Average FCF Margin over 5 years is 13.01%, with a median of 14.05% recorded in 2023.
  • The sharpest move saw FCF Margin crashed -3070bps in 2023, then surged 2201bps in 2024.
  • Year by year, FCF Margin stood at 24.63% in 2021, then plummeted by -35bps to 15.91% in 2022, then crashed by -193bps to 14.79% in 2023, then skyrocketed by 149bps to 7.22% in 2024, then crashed by -51bps to 3.51% in 2025.
  • Business Quant data shows FCF Margin for LLY at 3.51% in Q4 2025, 38.34% in Q3 2025, and 8.93% in Q2 2025.